Saizen in Intra-uterine Growth Retardation

Clinical trial NCT01400698 · COMPLETED

Trial details

NCT number: NCT01400698
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Children Born With Serious Intra-uterine Growth Retardation

Start date: 1998-11-01
Primary completion: 2010-02-01
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.